1290 AVENUE OF THE AMERICAS,
NEW YORK , NY, 10104

Rank

Rank Universe

Summary

The fund seeks long term capital appreciation by investing in companies outside the U.S.

The investment process considers companies of all markets capitalization and in developed regions and emerging markets. Then the team of analysts identifies companies with superior growth track record and prospects, solid financial strengths and established with market niches.

The team then also considers economic, regulatory and social More

Link

Directors

Nov 7, 2023
  • Ami Kaplan
  • George W. Morriss
  • Joseph V. Amato
  • Deborah C. Mclean
  • James G. Stavridis
  • Michael M. Knetter
  • Franklyn E. Smith
  • Michael J. Cosgrove
  • Tom D. Seip
  • Marc Gary
  • Martha C. Goss

Chief Compliance Officer

  • Savonne L. Ferguson

Fund Manager(s)

Price

  • $ 13.55 ( +0.05 )
    Nov 1, 2024
    Last Close
  • Net Assets
  • $1B
    Apr 24, 2024
  • Holding
  • 93
    Jul 29, 2024
    More

  • 52-Week High/Low
  • $14.45 - $11.35
  • Turnover
  • 45%
  • Expense Ratio
  • 1.03%

Company Name

Holding

ASML Holding NV 3.48 %
AstraZeneca PLC 2.43 %
State Street Global Advisors 2.09 %
Experian PLC 2.08 %
Hitachi Ltd 2.06 %
London Stock Exchange Group PLC 1.97 %
Novo Nordisk A/S 1.79 %
Shell PLC 1.77 %
Symrise AG 1.76 %
RELX PLC 1.71 %
More 1.71 %

Documents

Prospectus

Annual Reports

Performance

YTD

1.3%

3 Year

-20.25%

5 Year

1.12%

Best

36.97%

2009

Worst

-100%

2002

Alpha

NBIIX S&P 500

Chart +